|
|
Volumn 96, Issue 4, 2004, Pages 259-
|
|
IOM report targets testosterone therapy
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
PROSTATE SPECIFIC ANTIGEN;
TESTOSTERONE;
ADVISORY COMMITTEE;
AGING;
APOPTOSIS;
CANCER RESEARCH;
CELL PROLIFERATION;
CLINICAL STUDY;
CLINICAL TRIAL;
COGNITIVE DEFECT;
DEPRESSION;
DRUG APPROVAL;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG SAFETY;
GENE EXPRESSION;
HORMONAL THERAPY;
HORMONE SUBSTITUTION;
HUMAN;
HYPOGONADISM;
MALE;
NOTE;
OSTEOPOROSIS;
PRESCRIPTION;
PRIORITY JOURNAL;
PROSTATE CANCER;
RISK ASSESSMENT;
RISK BENEFIT ANALYSIS;
SEXUAL DYSFUNCTION;
SEXUALITY;
TESTOSTERONE SYNTHESIS;
|
|
EID: 1342269854
PISSN: 00278874
EISSN: None
Source Type: Journal
DOI: 10.1093/jnci/96.4.259 Document Type: Note |
|
Times cited : (7)
|
|
References (0)
|